Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy

We sought to quantify contribution of radiomics and SUVmax at PET/CT to predict clinical outcome in lung cancer patients treated with stereotactic body radiotherapy (SBRT). 150 patients with 172 lung cancers, who underwent SBRT were retrospectively included. Radiomics were applied on PET/CT. Princip...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Sci Rep
Main Authors: Oikonomou, Anastasia, Khalvati, Farzad, Tyrrell, Pascal N., Haider, Masoom A., Tarique, Usman, Jimenez-Juan, Laura, Tjong, Michael C., Poon, Ian, Eilaghi, Armin, Ehrlich, Lisa, Cheung, Patrick
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group UK 2018
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5838232/
https://ncbi.nlm.nih.gov/pubmed/29507399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-22357-y
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים